Atlas Brown,Inc. Abb Vie Inc. Transaction History

Atlas Brown,Inc.

$272 Million
Q1 2024

A detailed history of Atlas Brown,Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Atlas Brown,Inc. holds 31,107 shares of ABBV stock, worth $5.34 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares

31,107

Previous 30,021 3.62%

Holding current value

$5.34 Million

Previous $4.65 Million 21.75%

% of portfolio

2.08%

Previous 1.96%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 08, 2024	BUY	$159.82 - $182.1 $173,564 - $197,760	1,086 Added 3.62%	31,107 $5.66 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $275 - $309	2 Added 0.01%	30,021 $4.65 Million
Q3 2023 Oct 17, 2023	SELL	$133.59 - $154.65 $8,816 - $10,206	-66 Reduced 0.22%	30,019 $4.47 Million
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $1,987 - $2,473	15 Added 0.05%	30,085 $4.05 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $18,943 - $21,816	131 Added 0.44%	30,070 $4.79 Million

Q4 2022 Jan 05, 2023	SELL	$138.31 - $165.87 $350,477 - $420,314	-2,534 Reduced 7.8%	29,939 $0
Q3 2022 Oct 06, 2022	SELL	$134.21 - $153.93 $100,925 - $115,755	-752 Reduced 2.26%	32,473 $4.36 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $9,220 - $11,722	67 Added 0.2%	33,225 $5.09 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $40,781 - $50,598	-309 Reduced 0.92%	33,158 $5.38 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $53,929 - $68,236	502 Added 1.52%	33,467 $4.53 Million
Q3 2021 Oct 14, 2021	BUY	$106.4 - $120.78 $120,444 - $136,722	1,132 Added 3.56%	32,965 $3.56 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $185,169 - $206,289	1,760 Added 5.85%	31,833 $3.59 Million
Q1 2021 Apr 13, 2021	BUY	$102.3 - $112.62 $51,866 - $57,098	507 Added 1.71%	30,073 $3.26 Million
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $42,820 - $57,812	532 Added 1.83%	29,566 $3.17 Million
Q3 2020 Oct 15, 2020	BUY	$85.91 - $100.83 $6,529 - $7,663	76 Added 0.26%	29,034 $2.54 Million
Q2 2020 Jul 21, 2020	BUY	$73.37 - $98.18 $88,851 - $118,895	1,211 Added 4.36%	28,958 $2.84 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $42,183 - $63,954	654 Added 2.41%	27,747 $2.11 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $158,325 - $198,098	2,195 Added 8.82%	27,093 $2.4 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $92,832 - $111,611	-1,474 Reduced 5.59%	24,898 $1.89 Million
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $30,747 - $39,302	468 Added 1.81%	26,372 $1.92 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $122,884 - $144,628	-1,593 Reduced 5.79%	25,904 $2.09 Million
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $209,727 - $258,650	-2,694 Reduced 8.92%	27,497 $2.54 Million
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $89,710 - $99,729	-1,009 Reduced 3.23%	30,191 $2.86 Million
Q2 2018 Jul 11, 2018	BUY	$89.78 - $106.23 $54,586 - $64,587	608 Added 1.99%	31,200 $302,000
Q1 2018 Apr 17, 2018	BUY	$92.01 - $123.21 $74,068 - $99,184	805 Added 2.7%	30,592 $2.9 Million
Q4 2017 Jan 25, 2018	SELL	$89.56 - $98.21 $122,518 - $134,351	-1,368 Reduced 4.39%	29,787 $3.14 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $2.18 Million - $2.78 Million	31,155	31,155 $2.77 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Brown,Inc. with notifications on news.

Account